The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases
Kennedy NeuroMed Research Foundation is a Vancouver-based Canadian Registered Charity that operates a donor-matching platform directing individual and corporate contributions to vetted research projects in cancer, neuroimmunology, and degenerative diseases.
- Company typePrivate
- Founded2016
- HeadquartersVancouver, Canada
- Headcount1–10
- GTM typeB2C
- OfferingServices
What The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases does
Kennedy NeuroMed Research Foundation is a Canadian Registered Charity (Business number 850425174RR0001, established November 1, 2016) headquartered in Vancouver, British Columbia. Originally operating as The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases, it rebranded to Kennedy NeuroMed Research Foundation to sharpen its focus on neuro-medical research while continuing to fund cancer and degenerative disease work. The foundation operates a donor-to-research-project matching platform that allows individual donors, corporate sponsors, and grassroots advocates to direct contributions to specific research campaigns in three focus areas: Cancer (with a featured Triple Negative Breast Cancer campaign targeting a $10,000 in-vitro testing goal), Neuroimmunology (complement therapies), and Degenerative Diseases (Alzheimer's, Parkinson's, Multiple Sclerosis). It also maintains a General Account for operational expenses and discretionary funding of vetted cutting-edge proposals.
The foundation's core 'product' is a charitable giving platform paired with a stage-based research funding model. Rather than underwriting entire multi-year research scopes, the foundation funds research at stages to accelerate time-to-result, with the board vetting proposals and donors selecting where funds are directed. The website functions as the primary 24/7 donation and project-tracking interface, supplemented by an email newsletter, social media, and a Warrior volunteer community program organized around a 'Power of One' model (communicate, donate, action with purpose). Published scientific credibility is anchored by a 2016 paper in the Journal of Alzheimer's Disease on saliva-based Alzheimer's diagnosis, which was the most-read paper by Medical Geneticists that month per Medscape, and a March 2018 feature in the JAD 20th Anniversary Edition.
The organization is founder-led by Krista Kennedy and governed by a board with strong scientific credentials, including Dr. Steven Pelech (UBC Professor, founder of Kinetek Pharmaceuticals and Kinexus Bioinformatics), Dr. Patrick L. McGeer (National Academy of Inventors Fellow and leading Alzheimer's researcher), and Dr. Douglas N. Bell (retired Scripps Clinic head and neck surgeon). Revenue comes exclusively from donations, corporate matching, and sponsorships, with no pricing model or commercial revenue. The foundation adheres to the Association of Fundraising Professionals Code of Ethics and Donor Bill of Rights. Scale signals are modest: only one Founding Sponsor is named (Georgia Love Photography), no headcount is disclosed, no funding rounds exist, and there are no patents, awards, or technology integrations beyond the Squarespace-hosted website.
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases firmographics
Firmographics- Name
- The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases
- Legal name
- Kennedy NeuroMed Research Foundation
- Website
- https://thekennedyfoundation.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Kennedy NeuroMed Research Foundation is a Vancouver-based Canadian Registered Charity that operates a donor-matching platform directing individual and corporate contributions to vetted research projects in cancer, neuroimmunology, and degenerative diseases.
- Ownership category
- akta.pro rank
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases industry classification
Industry- Product category
- Charitable Medical Research Funding
- NAICS
- Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
- SIC
- Services-Social Services (8300)
- akta.pro industry
- Health & Medical Research Grantmaking FoundationsResearch & Science Grantmaking FoundationsDisease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
Keywords
Where The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Marketing or Sales, Others
Revenue model
- Donations and Fundraising: Primary revenue stream through individual donations, corporate matching, and sponsorship programs. Donors can direct funds to specific research projects or the General Account for operational expenses and flexible funding allocation.
- Sponsorship Programs: Corporate sponsorships including Founding Sponsor tier for companies wanting to support medical science research.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases product offering
Product offeringCore offering
Kennedy NeuroMed Research Foundation operates a donor-to-research project matching platform that channels charitable donations into vetted cutting-edge medical science research projects. Donors select specific research campaigns (Cancer/TNBC, Neuroimmunology/Complement Therapies, Degenerative Diseases including Parkinson's, Alzheimer's and Multiple Sclerosis) or contribute to the General Account for operational flexibility, with stage-based funding designed to accelerate research outcomes.
Product overview
Kennedy NeuroMed Research Foundation operates a donor-matching platform that connects supporters to medical science research projects across three focus areas: Cancer (specifically Triple Negative Breast Cancer), Neuroimmunology (Complement Therapies), and Degenerative Diseases (including Parkinson's, Alzheimer's, and Multiple Sclerosis). The platform allows donors to designate their contributions to specific projects or the General Account, which provides flexible funding for cutting-edge research proposals. The foundation is a Canada Revenue Agency Registered Public Charity established in 2016.
Differentiator
Problem solved
Functional benefit
Products and services
- Triple Negative Breast Cancer (TNBC) Research A fundraising campaign supporting in-vitro testing of Triple Negative Breast Cancer cell lines against a new non-toxic compound to assess effectiveness against this aggressive form of breast cancer.
- Neuroimmunology Complement Therapies Research A fundraising initiative supporting complement therapies research focused on the immune system's role in cancer and degenerative diseases, building a funding pool to attract qualified research applications.
- Degenerative Diseases Research Research funding for degenerative diseases including Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis, supporting successful research proposals aligned with the foundation's goals.
- General Account A multipurpose donation fund that covers operating expenses while allowing the board to seek cutting edge research projects, providing flexibility to redirect funds to projects needing additional support to complete funding goals.
- Donor-to-Research Project Matching Platform A charitable giving platform that matches donor interest to specific medical science research projects, allowing donors to select projects, follow outcomes, and track contributions through a transparent funding model.
Quantifiable outcome
- Registered as Canadian charity (Business number 850425174RR0001) since November 1, 2016
- +1 more outcomes
Companies that use The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases
Customer profileSegments3 records
Ideal customer profiles2 records
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- Georgia Love PhotographyminorListed as a Founding Sponsor providing support to the foundation. Located in Vancouver, BC.
- Association of Fundraising ProfessionalsminorThe foundation follows the Association of Fundraising Professionals Code of Ethics and Donor Bill of Rights.
Scale indicators3 records
Recent moves7 records
Expansion highlights4 records
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases competitors and assessment
Company assessmentDirect peers
- Michael J. Fox Foundation for Parkinson's Research: A high-profile nonprofit that funds Parkinson's disease research through donor contributions and a transparent grantmaking model. Directly comparable as a disease-specific medical research grantmaker with strong donor-directing ethos, though operates at significantly greater scale.
- Breast Cancer Society of Canada: Canadian charity focused specifically on funding breast cancer research through donor contributions. Directly comparable as a Canadian-domiciled, disease-specific research grantmaker competing for the same donor base interested in cancer research funding.
- Cancer Research Institute: US-based nonprofit dedicated to funding immunotherapy and cancer immunology research through donor contributions. Highly comparable as a research-focused grantmaking foundation operating in the cancer and immunology space overlapping with Kennedy Foundation's neuroimmunology and cancer focus.
Broad incumbents
- Alzheimer's Association: Largest nonprofit funder of Alzheimer's research globally, with a donor-funded grantmaking model that closely mirrors Kennedy Foundation's approach to funding degenerative disease research. Comparable as a competing destination for donors interested in Alzheimer's and dementia research.
- Canadian Cancer Society: Canada's largest national charity dedicated to cancer research, support, and advocacy. Directly comparable as a donor-funded medical research organization that funds cancer research grants, but operates at vastly larger scale and a broader mission than Kennedy Foundation's cancer-specific focus.
- National Multiple Sclerosis Society: Large US-based nonprofit funding MS research and providing patient services through donations. Comparable as a disease-specific research grantmaker where MS is one of Kennedy Foundation's focus areas, representing a competing donor destination.
Regional players
- BC Cancer Foundation: British Columbia-based charity that funds cancer research and care at BC Cancer. Directly comparable as a regionally focused Canadian medical research grantmaker with headquarters in Vancouver, competing for the same local donor and corporate sponsor base.
- ALS Society of Canada: Canadian charity funding ALS research and patient support through donations. Comparable as a Canadian-domiciled disease-specific medical research grantmaker, though focused on ALS rather than Kennedy Foundation's disease focus areas.
- Pancreatic Cancer Canada: Canadian charity focused exclusively on funding pancreatic cancer research through donations. Comparable as a small, disease-specific Canadian medical research grantmaker facing similar scale challenges to Kennedy Foundation in attracting donor attention against larger incumbents.
- Alzheimer Society of Canada: Canadian national charity funding Alzheimer's research and providing support services across Canada. Directly comparable as a Canadian-domiciled donor-funded medical research charity with headquarters overlap, competing for the same Canadian donor base interested in Alzheimer's and dementia research.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases social profiles
Digital presenceThe Kennedy Foundation for Cancer, Immunology and Degenerative Diseases financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases leadership team
Management profileNumber of profiles
Profiles5 records
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases
What does The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases do?
Kennedy NeuroMed Research Foundation operates a donor-to-research project matching platform that channels charitable donations into vetted cutting-edge medical science research projects. Donors select specific research campaigns (Cancer/TNBC, Neuroimmunology/Complement Therapies, Degenerative Diseases including Parkinson's, Alzheimer's and Multiple Sclerosis) or contribute to the General Account for operational flexibility, with stage-based funding designed to accelerate research outcomes.
Is The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases a public or private company?
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases founded?
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases was founded in 2016. It employs 1 to 10 people.
Where is The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases based?
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases is headquartered in Vancouver, Canada, in the North America region.
How does The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases make money?
Two revenue lines are on record. Donations and Fundraising is the primary driver. The others are sponsorship Programs.
Who are The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases's main competitors?
Direct peers on record are Michael J. Fox Foundation for Parkinson's Research, Breast Cancer Society of Canada and Cancer Research Institute. Broad incumbents are Alzheimer's Association, Canadian Cancer Society and National Multiple Sclerosis Society. Regional players are BC Cancer Foundation, ALS Society of Canada, Pancreatic Cancer Canada and Alzheimer Society of Canada.
Does The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases have an API?
No public API is recorded for The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases.
What industry is The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases in?
The Kennedy Foundation for Cancer, Immunology and Degenerative Diseases's product category is Charitable Medical Research Funding. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8300.